RIEMSER sells, licenses, markets and distributes pharmaceutical products. Over 400 approvals worldwide, of which 28 were gran ... ted in the last three years, stand testament to the special expertise of RIEMSER for the approval and opening of new markets for pharmaceutical products. The product range specifically covers prescription drugs used to treat serious diseases in the therapeutic areas of oncology, infectiology, neurology, cardiovascular, dermatology, and rheumatology, as well as the treatment of tuberculosis, obesity and primary axillary hyperhidrosis. Medicinal products and food supplements complement the portfolio. Besides its international group headquarters in Berlin, the company has three other locations in Germany. In 2014 and 2015, RIEMSER acquired the subsidiaries Keocyt based in France and Intrapharm based in England. Since October 2019, RIEMSER is also present in Spain through its subsidiary RIEMSER Iberia. In addition, it has established an international distribution network. RIEMSER is a portfolio company of Ardian, one of the world’s leading private investment companies. read more